Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Chubb
Citi
Teva
QuintilesIMS
Mallinckrodt
Covington
AstraZeneca
Colorcon

Generated: October 19, 2017

DrugPatentWatch Database Preview

Enalapril maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for enalapril maleate and what is the scope of enalapril maleate freedom to operate?

Enalapril maleate
is the generic ingredient in seven branded drugs marketed by Watson Labs, Silvergate Pharms, Sandoz Inc, Sandoz, Sun Pharm Inds Ltd, Taro, Krka Dd Novo Mesto, Mylan, Apotex, Teva, Ivax Sub Teva Pharms, Apothecon, Wockhardt Usa, Valeant Pharms North, Astrazeneca, Dr Reddys Labs Ltd, Upsher-smith Labs, Valeant Intl, G And W Labs Inc, Apotex Inc, and Taro Pharm Inds, and is included in twenty-eight NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Enalapril maleate has four patent family members in three countries.

There are twenty-seven drug master file entries for enalapril maleate. Forty suppliers are listed for this compound.

Summary for Generic Name: enalapril maleate

US Patents:3
Tradenames:7
Applicants:21
NDAs:28
Drug Master File Entries: see list27
Suppliers / Packagers: see list40
Bulk Api Vendors: see list68
Clinical Trials: see list278
Patent Applications: see list6,092
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:enalapril maleate at DailyMed

Pharmacology for Ingredient: enalapril maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075556-002Aug 22, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Krka Dd Novo Mesto
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075370-001Aug 22, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075048-004Aug 22, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Taro
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075657-004Jan 23, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075501-003Aug 22, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075480-004Aug 22, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075178-003Mar 23, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE
enalapril maleate; hydrochlorothiazide
TABLET;ORAL076116-001Sep 19, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Wockhardt Usa
ENALAPRIL MALEATE
enalapril maleate
TABLET;ORAL075483-001Aug 22, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
LEXXEL
enalapril maleate; felodipine
TABLET, EXTENDED RELEASE;ORAL020668-002Oct 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enalapril maleate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-005Jul 26, 1988► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-002Dec 24, 1985► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-003Dec 24, 1985► Subscribe► Subscribe
Valeant Pharms North
VASOTEC
enalapril maleate
TABLET;ORAL018998-001Dec 24, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: enalapril maleate

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2017161339► Subscribe
World Intellectual Property Organization (WIPO)2014055667► Subscribe
European Patent Office2903690► Subscribe
Canada2887379► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Novartis
Queensland Health
Mallinckrodt
US Army
US Department of Justice
Daiichi Sankyo
Express Scripts
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot